Feline Respiratory Infections: Etiology, Clinical Presentation, and Diagnostic Approach

Introduction

Feline respiratory infections represent a complex of clinical syndromes affecting the upper and lower respiratory tracts of domestic cats. These infections are among the most common reasons for veterinary consultations worldwide. Understanding the etiological agents, their pathogenesis, and the clinical signs they produce is essential for accurate diagnosis and appropriate management. The term "what is a respiratory infection in cats" encompasses a range of conditions from mild serous rhinitis to severe pneumonic disease. The primary etiological agents include viral pathogens such as feline herpesvirus-1 (FHV-1) and feline calicivirus (FCV), as well as bacterial pathogens including Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis (Greene, 2012). Co-infections are common, with viral agents often predisposing the host to secondary bacterial invasion (Sykes, 2014). This article provides a comprehensive review of the etiology, clinical presentation, and diagnostic approach for feline respiratory infections, emphasizing molecular and microbiological methods.

Etiology of Feline Respiratory Infections

Viral Pathogens

Feline herpesvirus-1 (FHV-1) is an enveloped, double-stranded DNA virus belonging to the family Herpesviridae, subfamily Alphaherpesvirinae (Gaskell & Willoughby, 1999). The virus replicates in the mucosal epithelium of the upper respiratory tract, conjunctiva, and cornea, causing cytolytic damage. Viral shedding occurs through ocular, nasal, and oral secretions. A defining feature of FHV-1 is its ability to establish latent infections in the trigeminal ganglia, with recrudescence triggered by stress, corticosteroid administration, or immunosuppression (Gaskell & Willoughby, 1999). FHV-1 accounts for a substantial proportion of acute feline upper respiratory disease cases.

Feline calicivirus (FCV) is a non-enveloped, single-stranded RNA virus classified within the family Caliciviridae (Radford et al., 2007). FCV exhibits significant antigenic diversity, with numerous field strains circulating in populations. The virus primarily targets the oral mucosa, upper respiratory epithelium, and pulmonary tissue. FCV infection can cause vesicular lesions on the tongue and hard palate, and highly virulent systemic strains (VS-FCV) can lead to severe systemic disease with high mortality (Radford et al., 2007). Recombination and mutation events contribute to the emergence of novel strains.

Bacterial Pathogens

Bordetella bronchiseptica is a Gram-negative, aerobic coccobacillus that colonizes the ciliated respiratory epithelium (Binns et al., 1993). This bacterium adheres to cilia via filamentous hemagglutinin and pertactin, leading to ciliostasis and mucociliary clearance impairment. B. bronchiseptica is a primary pathogen in kennel environments, especially in crowded and stressful conditions (Binns et al., 1993). The bacterium can survive in the environment for extended periods.

Chlamydia felis is an obligate intracellular Gram-negative bacterium that primarily infects conjunctival epithelial cells (Sykes, 2005). The organism exists in two developmental forms: the infectious elementary body (EB) and the replicating reticulate body (RB). C. felis is a major cause of feline conjunctivitis, often presenting with serous to mucopurulent ocular discharge. It can also cause mild upper respiratory signs (Sykes, 2005). The bacterium is transmitted via direct contact with infected ocular and nasal secretions.

Mycoplasma felis is a wall-less bacterium belonging to the class Mollicutes (Brown et al., 1991). Mycoplasmas lack a peptidoglycan cell wall, rendering them resistant to beta-lactam antibiotics and necessitating specialized culture media. M. felis colonizes the mucosal surfaces of the respiratory tract, conjunctiva, and joints. It can act as a primary or secondary pathogen, contributing to conjunctivitis, rhinitis, and lower respiratory disease, particularly in immunocompromised or young cats (Brown et al., 1991).

Other Pathogens

Pasteurella multocida, Streptococcus spp., and Escherichia coli are occasionally identified as secondary bacterial invaders in feline respiratory disease. These agents typically exacerbate existing viral or primary bacterial infections. Cryptococcus neoformans, a fungal pathogen, can cause granulomatous rhinitis and pneumonia in immunocompromised cats but is less common than viral and bacterial agents (Sykes, 2014). Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are retroviruses that predispose infected cats to more severe and persistent respiratory infections due to immunosuppression (Greene, 2012).

Transmission and Epidemiology

Transmission occurs primarily through direct contact with infected secretions (ocular, nasal, oral) or fomites (food bowls, bedding, human hands). FHV-1 and FCV are readily transmitted in multi-cat environments such as shelters, catteries, and boarding facilities. B. bronchiseptica is spread via aerosolized droplets. C. felis and M. felis require close contact for transmission. The incubation period varies by agent: FHV-1 and FCV (2-6 days), B. bronchiseptica (5-10 days), C. felis (3-10 days). Carrier states exist for FHV-1 (latent) and FCV (persistent shedding) (Gaskell & Willoughby, 1999; Radford et al., 2007).

Clinical Presentation

Clinical signs of feline respiratory infections vary in severity depending on the primary pathogen, host immune status, and presence of co-infections.

Signs Associated with FHV-1

FHV-1 typically causes acute upper respiratory disease with severe conjunctivitis, serous to mucopurulent ocular discharge, nasal discharge, sneezing, and anorexia. Affected cats often exhibit fever and depression. The virus can cause ulcerative keratitis with dendritic corneal ulcers, a hallmark feature (Gaskell & Willoughby, 1999). FHV-1 conjunctivitis is marked by chemosis (conjunctival edema) and hyperemia. In kittens, severe ophthalmia neonatorum can occur. Lower respiratory involvement (pneumonia) is rare in adults but possible in neonates (Greene, 2012).

Signs Associated with FCV

FCV infection generally produces milder upper respiratory signs compared to FHV-1, with a characteristic predominance of oral lesions. Ulcerative stomatitis and glossitis are common, with vesicles on the tongue, hard palate, and lips. Hypersalivation and oral discomfort lead to anorexia. Ocular and nasal discharge may be present but are less pronounced than in FHV-1 infection. Pneumonia can occur in naive kittens (Radford et al., 2007). Systemic calicivirus (VS-FCV) presents with pyrexia, ulcerative dermatitis, pulmonary edema, icterus, and high mortality (Radford et al., 2007).

Signs Associated with Bacterial Agents

Bordetella bronchiseptica infection typically manifests as acute or chronic bronchitis, marked by paroxysmal coughing, sneezing, mucopurulent nasal discharge, and submandibular lymphadenopathy (Binns et al., 1993). The cough can be productive or non-productive.

Chlamydia felis primarily causes conjunctivitis, often bilateral. The discharge progresses from serous to mucopurulent. Chemosis is frequently severe. Ocular pain is evidenced by blepharospasm and photophobia. Rhinitis may be present but is typically mild (Sykes, 2005).

Mycoplasma felis infection produces conjunctival hyperemia, chemosis, and serous to mucoid ocular discharge. It can also cause sneezing and mild rhinitis. In immunocompromised cats, lower respiratory involvement leads to coughing, dyspnea, and pulmonary infiltrates (Brown et al., 1991).

Systemic and Zoonotic Considerations

Systemic signs of feline respiratory infections include pyrexia, anorexia, depression, and weight loss. In young or immunocompromised cats, severe disease can lead to interstitial pneumonia, sepsis, and death. Zoonotic potential is minimal for most feline respiratory agents. B. bronchiseptica can infect immunocompromised humans (e.g., HIV patients), but human infection is rare. C. felis has been reported in immunocompromised individuals with conjunctivitis (Sykes, 2005). FHV-1, FCV, and M. felis are not zoonotic. However, good hygiene is always advisable. For additional detail on zoonotic risk, refer to the article on Feline Respiratory Infections: Etiology, Zoonotic Risk, and Diagnostic Approach.

Diagnostic Approach

A systematic diagnostic approach for feline respiratory infections integrates history, physical examination, and laboratory testing. The goal is to identify the primary etiological agent to guide treatment and implement control measures.

Sample Collection

Sample collection technique is critical for diagnostic accuracy. For acute respiratory disease, a deep oropharyngeal or nasal swab should be obtained using a sterile swab. For suspected FHV-1, conjunctival swabs are recommended. For C. felis and M. felis, deep conjunctival sampling is optimal. Swabs should be placed in viral transport medium for PCR and culture (Sykes, 2014). Acute and convalescent serum samples (collected 2-3 weeks apart) can be used for serology (Greene, 2012).

Molecular Diagnostics: Polymerase Chain Reaction (PCR)

Polymerase chain reaction (PCR) is the test of choice for detecting FHV-1, FCV, B. bronchiseptica, C. felis, and M. felis due to its high sensitivity and specificity (Sykes, 2014). Real-time PCR allows quantitation of pathogen load. Multiplex PCR panels that simultaneously detect multiple pathogens are widely available (Radford et al., 2007). PCR cannot differentiate between active infection and latent/latent shedding; positive results must be interpreted in clinical context. A positive FHV-1 PCR result with high CT cycles may indicate recrudescence rather than primary infection (Gaskell & Willoughby, 1999). For C. felis, positive PCR in acute conjunctivitis confirms infection (Sykes, 2005).

Virus Isolation and Culture

Virus isolation is a classical method often used for FCV detection, using cell lines such as CRFK cells (Radford et al., 2007). FHV-1 can be isolated in cell culture, producing characteristic cytopathic effect (CPE) (Gaskell & Willoughby, 1999). Viral culture is still useful for antimicrobial susceptibility testing for bacteria, but it has largely been replaced by PCR for speed and sensitivity.

Bacterial Culture

Bacterial culture is performed for B. bronchiseptica using selective media (e.g., Bordet-Gengou agar). The bacterium is slow-growing but typically produces visible colonies within 48 hours (Binns et al., 1993). C. felis requires intracellular culture methods and is not routinely cultured in most diagnostic labs. M. felis requires specialized media such as Hayflick's medium containing serum and yeast extract (Brown et al., 1991). Culture sensitivity is lower than PCR.

Serology

Serological assays (e.g., ELISA, serum neutralization) detect antibodies against FHV-1, FCV, or B. bronchiseptica (Greene, 2012). Serology is less useful for acute diagnosis due to the need for paired samples and the prevalence of vaccinal antibodies. It is more appropriate for population serosurveillance than individual diagnosis.

Cytology and Histopathology

Cytological evaluation of conjunctival scrapings stained with Giemsa or Wright-Giemsa may reveal intracellular inclusion bodies (e.g., C. felis elementary bodies) (Sykes, 2005). Mycoplasmas appear as small basophilic cocci on cell surfaces. Cytology is low sensitivity (about 50% for C. felis). Histopathology of biopsy tissue may reveal viral cytopathic effects for FHV-1 and FCV.

Point-of-Care Testing

Rapid in-clinic tests (e.g., immunochromatographic assays) are available for FHV-1 and FCV antigen detection. These tests have moderate sensitivity compared to PCR and are best used as screening tools (Sykes, 2014). They are not recommended as confirmatory tests.

flowchart TD
    A[Clinical Signs: Sneezing, Ocular/Nasal Discharge, Conjunctivitis, Ulcers], > B{History and Physical Exam}
    B, > C[Acute Upper Respiratory Signs]
    B, > D[Chronic or Recurrent Signs]
    C, > E[Sample Collection: Oropharyngeal/Nasal/Conjunctival Swab]
    D, > E
    E, > F[PCR Panel for FHV-1, FCV, B. bronchiseptica, C. felis, M. felis]
    F, > G{Panel Results}
    G, Positive FHV-1, > H[Confirm Latent or Active? Clinical context; Consider serology for prevalence]
    G, Positive FCV, > I[Confirm with clinical signs and rule out systemic strain]
    G, Positive B. bronchiseptica, > J[Bacterial culture for sensitivity if chronic]
    G, Positive C. felis, > K[Conjunctival cytology (optional)]
    G, Positive M. felis, > L[Culture if PCR only positive; Rule out co-infections]
    G, Negative, > M[Consider lower respiratory disease (chest X-ray); Rule out fungal/parasitic]
    H, > N[Differential diagnosis: FCV, C. felis]
    I, > O[Treat symptomatically; Antiviral (famciclovir) if severe FHV-1 suspected]
    J, > P[Antimicrobial: Doxycycline or tetracycline]
    K, > Q[Topical ophthalmic tetracycline; Systemic doxycycline]
    L, > R[Antimicrobial: Doxycycline or azithromycin]
    N, > S[Re-test or culture if symptoms persist]

Treatment and Management

Treatment varies by pathogen. For FHV-1, supportive care (hydration, nutritional support, topical ophthalmic antiviral agents) is primary. Famciclovir, a systemic antiviral, is effective in reducing clinical signs (Sykes, 2014). For FCV, supportive care and oral hygiene (rinsing, soft food) are mainstays. For B. bronchiseptica, tetracyclines (doxycycline) or fluoroquinolones are effective. For C. felis, tetracyclines (doxycycline) or azithromycin are first-line. For M. felis, doxycycline or azithromycin is recommended (Brown et al., 1991). Prevention relies on vaccination (FHV-1, FCV) and reducing stress. For comprehensive treatment guidance, see the article on Bacterial Respiratory Infections in Cats: Etiology, Diagnosis, and Treatment.

Conclusion

Feline respiratory infections are multifactorial diseases involving viral and bacterial agents with overlapping clinical presentations. Accurate diagnosis requires the use of PCR-based molecular panels as the gold standard, supported by clinical history and examination. Understanding the distinct etiopathogenesis of each agent is critical for effective clinical management and outbreak control.

References

Binns, S. H., Dawson, S., Speakman, A. J., Cuevas, L. E., Hart, C. A., Gaskell, C. J., ... & Gaskell, R. M. (1993). A study of Bordetella bronchiseptica in cats. Veterinary Record, 132(23), 607-610.

Brown, D. R., Talkington, D. F., & Biberstein, E. L. (1991). Mycoplasma felis and Mycoplasma gateae in cats. Journal of Veterinary Internal Medicine, 5(4), 264-268.

Gaskell, R. M., & Willoughby, K. (1999). Feline herpesvirus-1: everything you wanted to know but were afraid to ask. Journal of Feline Medicine and Surgery, 1(4), 183-193.

Greene, C. E. (Ed.). (2012). Infectious diseases of the dog and cat (4th ed.). Saunders Elsevier.

Radford, A. D., Coyne, K. P., Dawson, S., Porter, C. J., & Gaskell, R. M. (2007). Feline calicivirus. Veterinary Research, 38(2), 319-335.

Sykes, J. E. (2005). Feline chlamydiosis. Clinical Techniques in Small Animal Practice, 20(3), 131-134.

Sykes, J. E. (2014). Canine and feline infectious diseases. Elsevier Saunders.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.